Reports Record Full Year Revenue of $1,088.6 Million, Reflecting 38% Growth Achieves 49% Growth in Adjusted EBITDA to Record $187.1 Million

7 дней назад · Pharmacy benefit services revenue was $107.9 million, a 2.0% increase as compared to the $105.8 million reported in the third quarter of 2023.

5 дней назад · Revenue: US$286.6m (up 2.0% from 3Q 2023). Net income: US$10.4m (down 35% from 3Q 2023). Profit margin: 3.6% (down from 5.7% in 3Q 2023).

In the year 2023, Progyny had annual revenue of $1.09B with 38.34% growth. Revenue (ttm). $1.14B. Revenue Growth. +10.24%. P/S Ratio.

Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

8 дней назад · Revenue was $286.6 million, a 2.0% increase as compared to the $280.9 million reported in the third quarter of 2023, primarily as a result of ...

1 нояб. 2024 г. · The revenue of Progyny with headquarters in the United States amounted to 1.1 billion U.S. dollars in 2023. The reported fiscal year ends on ...

19 сент. 2024 г. · Progyny Inc.'s stock tumbled 31% Thursday, to put it on track for its biggest-ever one-day decline, after the provider of fertility-care benefits for employers ...

In depth view into Progyny Revenue (Annual) including historical data from 2019, charts and stats.